| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARRAY BIOPHARMA INC COM | 16,658,072 | 112,442,000 | 8.94% | ||
| 2 | SEATTLE GENETICS INC | 1,781,470 | 96,217,000 | 7.65% | ||
| 3 | AMICUS THERAPEUTICS INC | 12,751,536 | 94,361,000 | 7.51% | ||
| 4 | CLOVIS ONCOLOGY INC | 2,049,985 | 73,902,000 | 5.88% | ||
| 5 | GW PHARMACEUTICALS PLC | 545,922 | 72,460,000 | 5.76% | ||
| 6 | INCYTE | 597,638 | 56,351,000 | 4.48% | ||
| 7 | PENUMBRA INC COM | 672,918 | 51,135,000 | 4.07% | ||
| 8 | MOLINA HEALTHCARE INC | 778,160 | 45,382,000 | 3.61% | ||
| 9 | ENDOLOGIX INC | 3,480,644 | 44,552,000 | 3.54% | ||
| 10 | PUMA BIOTECHNOLOGY | 662,286 | 44,406,000 | 3.53% | ||
| 11 | Atara Biotherapeutics Inc | 2,021,617 | 43,242,000 | 3.44% | ||
| 12 | PROTHENA CORP PLC | 701,659 | 42,078,000 | 3.35% | ||
| 13 | SAREPTA THERAPEUTICS INC | 640,400 | 39,327,000 | 3.13% | ||
| 14 | AGIOS PHARMACEUTICALS INC | 737,900 | 38,976,000 | 3.10% | ||
| 15 | CENTENE CORP DEL | 464,077 | 31,075,000 | 2.47% | ||
| 16 | ARIAD PHARMACEUTICALS INC | 2,138,471 | 29,276,000 | 2.33% | ||
| 17 | BOSTON SCIENTIFIC CORP | 1,072,638 | 25,529,000 | 2.03% | ||
| 18 | NANOSTRING TECHNOLOGIES INC | 1,237,435 | 24,724,000 | 1.97% | ||
| 19 | NEVRO CORP | 227,267 | 23,724,000 | 1.89% | ||
| 20 | OPHTHOTECH CORP COM | 505,154 | 23,303,000 | 1.85% | ||
| 21 | ALDER BIOPHARMACEUTICALS INC | 702,539 | 23,022,000 | 1.83% | ||
| 22 | WAVE LIFE SCIENCES LTD | 701,822 | 22,788,000 | 1.81% | ||
| 23 | PORTOLA PHARMACEUTICALS INC | 916,927 | 20,823,000 | 1.66% | ||
| 24 | Oxford Immunotec Global PLC | 1,431,119 | 17,975,000 | 1.43% | ||
| 25 | CHIMERIX INC | 3,214,946 | 17,811,000 | 1.42% | ||
| 26 | Model N Inc | 1,550,959 | 17,231,000 | 1.37% | ||
| 27 | Audentes Therapeutics, Inc. | 916,626 | 14,903,000 | 1.19% | ||
| 28 | NEURODERM LTD | 805,246 | 14,889,000 | 1.18% | ||
| 29 | SYROS PHARMACEUTICALS INC | 892,782 | 11,736,000 | 0.93% | ||
| 30 | CYTOMX THERAPEUTICS INC COM | 714,692 | 11,206,000 | 0.89% | ||
| 31 | CHARLES RIV LABS INTL INC | 127,106 | 10,593,000 | 0.84% | ||
| 32 | ASTRAZENECA PLC | 288,356 | 9,475,000 | 0.75% | ||
| 33 | SPECTRANETICS CORP | 334,741 | 8,399,000 | 0.67% | ||
| 34 | IRONWOOD PHARMACEUTICALS INC COM CL A | 408,462 | 6,486,000 | 0.52% | ||
| 35 | VCA INCORPORATED | 91,000 | 6,368,000 | 0.51% | ||
| 36 | ALEXION PHARMACEUTIC | 45,410 | 5,565,000 | 0.44% | ||
| 37 | INTRA CELLULAR THERAPIES INC COM | 336,759 | 5,132,000 | 0.41% | ||
| 38 | ARRAY BIOPHARMA INC 3 06/01/2020 | 4,000,000 | 4,761,000 | 0.38% | PRN | |
| 39 | INVITAE CORP | 510,369 | 4,471,000 | 0.36% | ||
| 40 | FATE THERAPEUTICS INC COM | 1,425,158 | 4,446,000 | 0.35% | ||
| 41 | ProQR Therapeutics NV | 575,863 | 3,841,000 | 0.31% | ||
| 42 | BLUEPRINT MEDICINES CORP COM | 27,539 | 818,000 | 0.07% | ||
| 43 | AURINIA PHARMACEUTICALS INC | 187,610 | 565,000 | 0.04% | ||
| 44 | FIRST TR EXCHANGE-TRADED FD | 3,090 | 308,000 | 0.02% | ||
| 45 | UNITEDHEALTH GROUP INC | 1,820 | 255,000 | 0.02% | ||
| 46 | HUMANA | 1,390 | 246,000 | 0.02% | ||
| 47 | DEXCOM | 2,460 | 216,000 | 0.02% | ||
| 48 | BIOGEN INC | 677 | 212,000 | 0.02% | ||
| 49 | ACHAOGEN INC COM | 32,300 | 155,000 | 0.01% | ||
| 50 | ADVERUM BIOTECHNOLOGIES INC | 22,236 | 91,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-16-000040, filed 2016.11.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
